Bioconvergence - The New Investment era in Health

Neighborhood is proud to Host ENV, a new Pan-European Venture Fund specializing in Healthtech. We are thrilled to host an exclusive evening dedicated to exploring the innovative realm of bioconvergence in healthcare investment. The event, set to feature industry-leading speakers and insightful discussions, aims to illuminate the transformative potential and current trends in bioconvergence, a field at the intersection of biology with digital and engineering technologies.

This special evening will include keynotes and a roundtable featuring prominent figures such as Marc De Garidel, CEO of Abivax, and Frederic Desdouits, CEO of Treefrog. Marc De Garidel will provide valuable insights from his rich experience in the biopharmaceutical sector, while Frederic Desdouits will discuss the strategic nuances of Treefrog's recent deal with Vertex Therapeutics, highlighting the journey and critical aspects of this significant partnership.

The event will conclude with a networking cocktail, offering attendees the opportunity to connect with peers, discuss the insights shared, and foster potential collaborations in a relaxed and engaging setting. This gathering is an invaluable occasion for professionals eager to stay at the forefront of healthcare innovation and investment.